These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 36650674)
21. Vanishing white matter: Eukaryotic initiation factor 2B model and the impact of missense mutations. Slynko I; Nguyen S; Hamilton EMC; Wisse LE; de Esch IJP; de Graaf C; Bruning JB; Proud CG; Abbink TEM; van der Knaap MS Mol Genet Genomic Med; 2021 Mar; 9(3):e1593. PubMed ID: 33432707 [TBL] [Abstract][Full Text] [Related]
22. Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease. Raini G; Sharet R; Herrero M; Atzmon A; Shenoy A; Geiger T; Elroy-Stein O J Neurochem; 2017 Jun; 141(5):694-707. PubMed ID: 28306143 [TBL] [Abstract][Full Text] [Related]
24. A point mutation in translation initiation factor eIF2B leads to function--and time-specific changes in brain gene expression. Marom L; Ulitsky I; Cabilly Y; Shamir R; Elroy-Stein O PLoS One; 2011; 6(10):e26992. PubMed ID: 22073122 [TBL] [Abstract][Full Text] [Related]
25. eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes. Herrero M; Mandelboum S; Elroy-Stein O Neuromolecular Med; 2019 Sep; 21(3):303-313. PubMed ID: 31134486 [TBL] [Abstract][Full Text] [Related]
26. The Energy Status of Astrocytes Is the Achilles' Heel of eIF2B-Leukodystrophy. Herrero M; Daw M; Atzmon A; Elroy-Stein O Cells; 2021 Jul; 10(8):. PubMed ID: 34440627 [TBL] [Abstract][Full Text] [Related]
27. A yeast purification system for human translation initiation factors eIF2 and eIF2Bε and their use in the diagnosis of CACH/VWM disease. de Almeida RA; Fogli A; Gaillard M; Scheper GC; Boesflug-Tanguy O; Pavitt GD PLoS One; 2013; 8(1):e53958. PubMed ID: 23335982 [TBL] [Abstract][Full Text] [Related]
28. Paradoxical Sensitivity to an Integrated Stress Response Blocking Mutation in Vanishing White Matter Cells. Sekine Y; Zyryanova A; Crespillo-Casado A; Amin-Wetzel N; Harding HP; Ron D PLoS One; 2016; 11(11):e0166278. PubMed ID: 27812215 [TBL] [Abstract][Full Text] [Related]
29. The large spectrum of eIF2B-related diseases. Fogli A; Boespflug-Tanguy O Biochem Soc Trans; 2006 Feb; 34(Pt 1):22-9. PubMed ID: 16246171 [TBL] [Abstract][Full Text] [Related]
30. Ovarioleukodystrophy due to EIF2B5 mutations. Ibitoye RT; Renowden SA; Faulkner HJ; Scolding NJ; Rice CM Pract Neurol; 2016 Dec; 16(6):496-499. PubMed ID: 27651498 [TBL] [Abstract][Full Text] [Related]
31. Identification of novel EIF2B mutations in Chinese patients with vanishing white matter disease. Wu Y; Pan Y; Du L; Wang J; Gu Q; Gao Z; Li J; Leng X; Qin J; Wu X; Jiang Y J Hum Genet; 2009 Feb; 54(2):74-7. PubMed ID: 19158808 [TBL] [Abstract][Full Text] [Related]
32. EIF2B2 gene mutation causing early onset vanishing white matter disease: a case report. Filareto I; Cinelli G; Scalabrini I; Caramaschi E; Bergonzini P; Spezia E; Todeschini A; Iughetti L Ital J Pediatr; 2022 Jul; 48(1):128. PubMed ID: 35897042 [TBL] [Abstract][Full Text] [Related]
33. Fifteen novel EIF2B1-5 mutations identified in Chinese children with leukoencephalopathy with vanishing white matter and a long term follow-up. Zhang H; Dai L; Chen N; Zang L; Leng X; Du L; Wang J; Jiang Y; Zhang F; Wu X; Wu Y PLoS One; 2015; 10(3):e0118001. PubMed ID: 25761052 [TBL] [Abstract][Full Text] [Related]
34. Isocaloric low protein diet in a mouse model for vanishing white matter does not impact ISR deregulation in brain, but reveals ISR deregulation in liver. Wisse LE; Visser D; Ter Braak TJ; Bakkali A; Struys EA; Morrison CD; van der Knaap MS; Abbink TEM Nutr Neurosci; 2022 Jun; 25(6):1219-1230. PubMed ID: 33236691 [No Abstract] [Full Text] [Related]
35. [Advances in functional study of EIF2B mutations in leukoencephalopathy with vanishing white matter]. Leng XR; Wu Y; Jiang YW Sheng Li Ke Xue Jin Zhan; 2010 Apr; 41(2):125-8. PubMed ID: 21416999 [No Abstract] [Full Text] [Related]
36. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Leegwater PA; Vermeulen G; Könst AA; Naidu S; Mulders J; Visser A; Kersbergen P; Mobach D; Fonds D; van Berkel CG; Lemmers RJ; Frants RR; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS Nat Genet; 2001 Dec; 29(4):383-8. PubMed ID: 11704758 [TBL] [Abstract][Full Text] [Related]
37. The small molecule ISRIB rescues the stability and activity of Vanishing White Matter Disease eIF2B mutant complexes. Wong YL; LeBon L; Edalji R; Lim HB; Sun C; Sidrauski C Elife; 2018 Feb; 7():. PubMed ID: 29489452 [TBL] [Abstract][Full Text] [Related]
38. Different Eukaryotic Initiation Factor 2Bε Mutations Lead to Various Degrees of Intolerance to the Stress of Endoplasmic Reticulum in Oligodendrocytes. Chen N; Jiang YW; Hao HJ; Ban TT; Gao K; Zhang ZB; Wang JM; Wu Y Chin Med J (Engl); 2015 Jul; 128(13):1772-7. PubMed ID: 26112719 [TBL] [Abstract][Full Text] [Related]
39. Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity. Richardson JP; Mohammad SS; Pavitt GD Mol Cell Biol; 2004 Mar; 24(6):2352-63. PubMed ID: 14993275 [TBL] [Abstract][Full Text] [Related]